PURIST: Peptides have entered the mainstream wellness culture almost overnight. Why are they being called the next frontier of preventive medicine?
Dr. Brandon Howard, co-founder and chief medical officer of Mino, board-certified internal medicine specialist practicing at Holy Name Medical Center and Hackensack University Medical Center in New Jersey: Peptides are short chains of amino acids. Your body already uses thousands of them as signaling molecules, telling cells when to repair, rest or rebuild. We’re not introducing anything foreign; we’re amplifying biology that’s already running. What makes them feel like a frontier is precision. Traditional medicine waits for disease to show up. A well-designed peptide protocol lets us nudge specific systems—metabolic, regenerative, immune—earlier, while there’s still margin to influence the trajectory. That’s the shift: from reacting to a diagnosis to anticipating one.
Health-conscious consumers are buying peptides directly from websites and hearing about them on podcasts. What makes that dangerous, and what does a physician-led infrastructure protect against?
BH: The vials being sold on websites and through podcast affiliate links are unregulated. You have no real way to know what’s inside—whether it’s sterile, or whether the label matches what’s in the bottle. We’ve seen contamination, mislabeling and outright counterfeits. At Mino, every compound is sourced from a 503A pharmacy we’ve personally vetted. A licensed physician reviews your labs and history before anything ships. That infrastructure isn’t bureaucracy; it’s the difference between therapy and a chemistry experiment on yourself.
There’s a real gap between marketing hype and scientific proof.
BH: Some peptides, the GLP-1 receptor agonist class, for example, have FDA approval, multiple Phase 3 trials and years of real-world safety data behind them. Others, like BPC-157 or TB-500, have compelling preclinical work and a lot of athlete enthusiasm, but the large human trials simply don’t exist yet. At Mino, every compound is graded by evidence tier, so patients understand whether they’re using a well-studied therapeutic or a more exploratory tool.
Longevity medicine is about optimizing health span, not just treating disease. How do peptide protocols help shift patient care from reactive to proactive?
BH: If fasting insulin is creeping up, if recovery from training is slipping, if sleep architecture is fragmenting, those are signals years before a diagnosis. Compounds like Mino’s GLP3-RT for metabolic resilience, paired with recovery-focused peptides for tissue repair, let us intervene at the slope rather than the cliff. Combined with labs, sleep, training and nutrition, the goal is more good years, not just more years.
People spend heavily on topical skin care, but peptides are increasingly being used systemically. How do internal protocols change the way we treat skin quality and aging at the cellular level?
Dr. Amy B. Lewis, co-founder, Mino, New York City board-certified dermatologist: Topical skin care still plays an important role in maintaining hydration, barrier function, even tone/pigmentation, along with protection from UV rays and other environmental exposures. Systemic peptide protocols shift the focus from surface-level correction to cellular signaling. Skin aging is not solely a superficial cosmetic issue. Changes in inflammation, mitochondrial efficiency, collagen synthesis, vascular health, hormonal signaling and tissue repair also contribute to this process. We’re moving toward a more integrative model, where skin quality reflects internal physiology, along with external skin care routines.
Many people treat peptides like advanced vitamins or biohacking tools they can self-manage. Why is physician oversight so critical for dosing, sequencing and long-term safety?
AL: One of the biggest misconceptions is that peptides are inherently low-risk simply because many are “natural” molecules. However, these compounds can influence endocrine pathways, inflammation, insulin signaling, immune activity, tissue growth and recovery processes. Dosing can be difficult to manage while minimizing side effects. A protocol that may be appropriate for one patient could be completely inappropriate for another, depending on metabolic health, cancer history, autoimmune disease, medications, baseline inflammation, or short- and long-term goals. Physician-guided treatment allows for proper monitoring, including blood work, dose adjustments and integration into a broader health strategy rather than isolated experimentation. This is why Mino has such a unique and exemplary platform. It allows not only for monitoring, but education to the patients and a source to ask questions and control any potential side effects. It also provides for the evolution of the peptide therapy to change with the various needs of the patient. mino.inc
Explore more in Wellness at The Purist.
Never miss an issue—join The Purist community.